Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000332

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
49.6 GB
File formats
  • FASTQ
Research
hum0195
Date published
2021-04-02
Date modified
2021-04-02
DDBJ Search
JGAD000332 (opens in a new tab)
JGA Study
JGAS000234 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication (ICD10: K746, C220): 20 cases
non-tumor tissues: 20 samples
hepatitis C virus positive cirrhosis and hepatocellular carcinoma (ICD10: K746, C220): 3 cases
tumor tissues: 8 samples
non-tumor tissues: 3 samples
hepatitis C virus negative hepatocellular carcinoma (ICD10: C220): 2 cases
tumor tissues: 7 samples
non-tumor tissues: 2 samples
gastric cancer (ICD10: C169): 6 cases
intestinal metaplasia (IM) 5 samples, non-IM 3samples
  • Health status
    Affected
  • Subject count
    31 (Individual)
Disease
liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication (K746, C220)
hepatitis C virus positive cirrhosis and hepatocellular carcinoma (K746, C220)
hepatitis C virus negative hepatocellular carcinoma (C220)
gastric cancer (C169)
Sample description
RNAs extracted from tumor tissues and non-tumor tissues of hepatocellular carcinoma
Total RNAs extracted from non-tumor tissues (only gland duct) of IM samples and non-IM samples
  • Tissue
    Liver, Stomach
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Library Prep Kit
Fragmentation
Enzymatic Fragmentation
Platform
Illumina HiSeq 4000
Illumina NovaSeq 6000
Read type
Paired-end
Read length
101 bp
Data use policy
NBDC data sharing policy (JGAP000001)